Clinical Registry on Sudden Death Primary Prevention at Latin America (ESCAPE-ICD)
Clinical Registry on Sudden Death Primary Prevention at Latin America (rEgiStro Clinico en America Latina de Prevencion Primaria en muErte Subita)
INTRODUCTION: Sudden cardiac death is one of the most important reasons of death at industrialized countries. Despite its importance, nowadays Clinical Guidelines are not as extended as expected, with respect to indications for primary prevention defibrillator implantation, following MADIT II and MUSTT criteria, especially at Latin American countries.
OBJECTIVES: This Project is designed with the purpose of providing tools to help spreading primary prevention by the means of clinical evidence on real risk of death in this group of patients.
REGISTRY DESIGN:
- retrospective (at stage 1); prospective (at stage 2)
- multi-center (minimum 25-30 centres)
- international (Argentina, Brazil, Colombia, Chile, Mexico and Venezuela)
- non randomized.
- Sample size: at screening about 12.500 patients and 962 patients at treatment stage
REGISTRY DEVICES: CE marked (Conformité Européenne) single-chamber, dual-chamber or CRT (Cardiac Resynchronization Therapy) implantable cardiac defibrillator (ICD).
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
REGISTRY STAGES 2 stages will be performed:
- Stage 1 (Screening): 12500 patients with MI and LVEF<40% will be evaluated, to know ICD implantation prevalence in such patients at Latin American countries
- Stage 2 (Treatment): after patient screening and as per clinical decision, 962 patients will be entered in group 1 and 2 (481 each, 1:1)
STEERING COMMITTEE
- Dr. Sergio Dubner. Clinica y Maternidad Suizo Argentina and De Los Arcos Sanatorio. Buenos Aires - Argentina
- Dr. William Uribe. CES CARDIOLOGIA. Medellin - Colombia
CLINICAL ASSESSMENT
• Dr Francisco Javier Alzueta Rodriguez. Hospital Clinico Universitario Virgen de la Victoria. Malaga - Spain
REGISTRY DURATION
- Patient enrollment period initiation: September 2011
- End of patient enrollment: September 2013
- End of FUs: September 2018
- Registry closure and data analyses: 4Q 2018.
REGULATORY CONSIDERATIONS As this is an observational registry, no submission to National Authorities is required.
Tipo de estudo
Contactos e Locais
Locais de estudo
-
-
-
Tucuman, Argentina
- Centro Privado de Cardiología
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Patients that had Acute Myocardial Infarction (>40 days post-AMI) documented with the presence of Q-wave or cardiac-specific enzymatic markers of myocardial necrosis (CK-MB/troponin), occurred within 3 years previous to enrollment / after June 2008.
- Left Ventricular Ejection Fraction (LVEF) ≤40% post-revascularization (if no revascularization, measurement performed <3 months previous to patient enrollment, >40 days post-AMI and >3 months post-revascularization -if applicable-).
Exclusion Criteria:
- Patient with an implanted ICD
- <18 years old
- Pregnant or breast feeding women
- Patients that are already participating in other Investigational Study or Registry
- Non signed patient informed consent or refusal from patient's reference physician to patient participation
- Patient inability to comply with protocol (assist to scheduled follow-ups), due to: residence displacement out of center's activity area; unstable geographical situation or at very long distance from the center; unstable medical and/or psychological condition
- Cardiac transplanted (or in transplant waiting list)
- Severe Heart Failure (or other co-morbidity: cancer, renal failure, etc.)
- Life expectancy lower than 1 year
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
ICD implantation
Patients that receive an ICD implantation (non randomized, by clinical decision) will enter this group
|
Standard ICD implantation (as per clinical decision)
Outros nomes:
|
|
Non ICD implantation
Patients that do not receive ICD implantation (non randomized, by clinical decision); they can receive any other treatment (e.g.
antiarrhythmic drugs)
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Prevalence of patients with MADIT, MADIT II and MUST at Latin American countries
Prazo: Patients that suffered from MI in the last 3 years and during the enrollment period
|
Primary Outcome at Stage 1: Determine prevalence of patients with myocardial infarction and high risk of sudden death at Latin America, that fulfill inclusion criteria Primary Outcome at Stage 2: Compare MACE development in patients that receive ICD implantation vs patients that receive other type of treatment (non ICD) |
Patients that suffered from MI in the last 3 years and during the enrollment period
|
Medidas de resultados secundários
Medida de resultado |
Prazo |
|---|---|
|
Study incidence of Arrhythmic mortality and serious arrhythmic events, evaluated through remote monitoring
Prazo: 5 years (until end 2018)
|
5 years (until end 2018)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Sergio J Dubner, MD, FACC, Clínica y Maternidad Suizo Argentina and De Los Arcos Sanatorio. Buenos Aires, Argentina
- Investigador principal: William Uribe, MD, CES Cardiología. Medellin, Colombia
- Cadeira de estudo: Francisco J Alzueta Rodriguez (Study Clinical Advisor), Dr, Hospital Clínico Universitario Virgen de la Victoria. Málaga, Spain
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- TA098
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .